Search Results - "Rettenbacher, M."

Refine Results
  1. 1

    Impact of childhood trauma on antipsychotic effectiveness in schizophrenia spectrum disorders: A prospective, pragmatic, semi-randomized trial by Mørkved, N., Johnsen, E., Kroken, R.A., Winje, D., Larsen, T.K., Thimm, J.C., Rettenbacher, M.A., Johannesen, C.A. Bartz, Løberg, E.-M.

    Published in Schizophrenia research (01-08-2022)
    “…Antipsychotic medications are generally effective in ameliorating psychotic symptoms in schizophrenia spectrum disorders (SSDs). Identifying predictors…”
    Get full text
    Journal Article
  2. 2

    Clinical insight among persons with schizophrenia spectrum disorders treated with amisulpride, aripiprazole or olanzapine: a semi-randomised trial by Stabell, L A, Johnsen, E, Kroken, R A, Løberg, E M, Blindheim, A, Joa, I, Reitan, S K, Rettenbacher, M, Munk-Jørgensen, P, Gjestad, R

    Published in BMC psychiatry (29-06-2023)
    “…Antipsychotic treatment may improve clinical insight. However, previous studies have reported inconclusive findings on whether antipsychotics improve insight…”
    Get full text
    Journal Article
  3. 3

    Childhood trauma types in relation to antipsychotic effectiveness in schizophrenia spectrum disorders: A prospective, pragmatic, randomized controlled study by Mørkved, N., Johnsen, E., Kroken, R.A., Joa, I., Kjelby, E., Rettenbacher, M.A., Bartz-Johannessen, C.A., Løberg, E-M

    Published in Psychiatry research (01-11-2024)
    “…•Some patients with schizophrenia do not respond favorably to antipsychotics.•Childhood trauma types may influence antipsychotic effectiveness in…”
    Get full text
    Journal Article
  4. 4

    Symptomatic remission and neurocognitive functioning in patients with schizophrenia by Hofer, A, Bodner, T, Kaufmann, A, Kemmler, G, Mattarei, U, Pfaffenberger, N M, Rettenbacher, M A, Trebo, E, Yalcin, N, Fleischhacker, W W

    Published in Psychological medicine (01-10-2011)
    “…A cross-sectional study was conducted in participants with schizophrenia to explore a potential association between the patients' remission status and…”
    Get more information
    Journal Article
  5. 5

    Metabolic side effects of antipsychotic medication by Tschoner, A, Engl, J, Laimer, M, Kaser, S, Rettenbacher, M, Fleischhacker, W W, Patsch, J R, Ebenbichler, C F

    “…The use of second-generation antipsychotics (SGAs) is associated with metabolic side effects including weight gain, diabetes mellitus and an atherogenic lipid…”
    Get more information
    Journal Article
  6. 6

    Does childhood trauma influence cognitive functioning in schizophrenia? The association of childhood trauma and cognition in schizophrenia spectrum disorders by Mørkved, N., Johnsen, E., Kroken, R.A., Gjestad, R., Winje, D., Thimm, J., Fathian, F., Rettenbacher, M., Anda, L.G., Løberg, E.M.

    Published in Schizophrenia research. Cognition (01-09-2020)
    “…Childhood trauma (CT) is a risk factor for schizophrenia spectrum disorders (SSDs), and cognitive impairment is a core feature and a vulnerability marker of…”
    Get full text
    Journal Article
  7. 7

    A multi-centre phase 3 study comparing efficacy and safety of Bemfola® versus Gonal-f® in women undergoing ovarian stimulation for IVF by Rettenbacher, M, Andersen, A.N, Garcia-Velasco, J.A, Sator, M, Barri, P, Lindenberg, S, van der Ven, K, Khalaf, Y, Bentin-Ley, U, Obruca, A, Tews, G, Schenk, M, Strowitzki, T, Narvekar, N, Sator, K, Imthurn, B

    Published in Reproductive biomedicine online (01-05-2015)
    “…Abstract Bemfola (follitropin alfa) (Finox AG, Switzerland), a new recombinant FSH, has a comparable pharmacological profile to that of Gonal-f (Merck Serono,…”
    Get full text
    Journal Article
  8. 8

    A multi-centre phase 3 study comparing efficacy and safety of Bemfola® versus Gonal-f® in women undergoing ovarian stimulation for IVF by Rettenbacher, M., Andersen, A.N., Garcia-Velasco, J.A.

    Published in Reproduktivnaâ èndokrinologiâ (27-05-2021)
    “…Bemfola (follitropin alfa) (Finox AG, Switzerland), a new recombinant FSH, has a comparable pharmacological profile to that of Gonal-f (Merck Serono, Germany),…”
    Get full text
    Journal Article
  9. 9

    Neutropenia induced by second generation antipsychotics: a prospective investigation by Rettenbacher, M A, Hofer, A, Kemmler, G, Fleischhacker, W W

    Published in Pharmacopsychiatry (01-03-2010)
    “…Clozapine is known to induce neutropenia as well as agranulocytosis. Some cases of olanzapine- and risperidone-induced neutropenia and agranulocytosis have…”
    Get more information
    Journal Article
  10. 10

    Subjective response and attitudes toward antipsychotic drug therapy during the initial treatment period: a prospective follow-up study in patients with schizophrenia by Hofer, A., Rettenbacher, M. A., Edlinger, M., Kemmler, G., Widschwendter, C. G., Fleischhacker, W. W.

    Published in Acta Psychiatrica Scandinavica (01-11-2007)
    “…Objective:  In this prospective study, patients with schizophrenia were followed up for 3 months to investigate the impact of sociodemographic factors,…”
    Get full text
    Journal Article
  11. 11

    Effects of six second generation antipsychotics on body weight and metabolism - risk assessment and results from a prospective study by Tschoner, A, Engl, J, Rettenbacher, M, Edlinger, M, Kaser, S, Tatarczyk, T, Effenberger, M, Patsch, J R, Fleischhacker, W W, Ebenbichler, C F

    Published in Pharmacopsychiatry (01-01-2009)
    “…Due to the association of second generation antipsychotics (SGAs) with weight gain and alterations of glucose and lipid homeostasis, we aimed to group six…”
    Get more information
    Journal Article
  12. 12

    Correlates of subjective and functional outcomes in outpatient clinic attendees with schizophrenia and schizoaffective disorder by Hofer, Alex, Rettenbacher, Maria A, Widschwendter, Christian G, Kemmler, Georg, Hummer, Martina, Fleischhacker, W Wolfgang

    “…Outcome in schizophrenia is multidimensional and, thus, consists of clinical,humanitarian, rehabilitative and cost domains. Accordingly, recovery is…”
    Get full text
    Journal Article
  13. 13

    Localization and characterization of neuropeptide receptors in human colon by Rettenbacher, M, Reubi, J C

    “…Information about the expression of neuropeptide receptors is limited in human peripheral tissues, such as the gastrointestinal tract, as compared to the…”
    Get full text
    Journal Article
  14. 14

    Outcomes in schizophrenia outpatients treated with amisulpride or olanzapine by Hofer, A, Rettenbacher, M A, Edlinger, M, Huber, R, Bodner, T, Kemmler, G, Sachs, G, Fleischhacker, W W

    Published in Pharmacopsychiatry (01-01-2007)
    “…We compared stable patients with schizophrenia who were treated with either amisulpride or olanzapine in terms of symptomatic outcome, neurocognitive…”
    Get more information
    Journal Article
  15. 15

    Childhood trauma in schizophrenia spectrum disorders as compared to substance abuse disorders by Mørkved, Nina, Winje, Dagfinn, Dovran, Anders, Arefjord, Kjersti, Johnsen, Erik, Kroken, Rune Andreas, Anda-Ågotnes, Liss-Gøril, Thimm, Jens C., Sinkeviciute, Igne, Rettenbacher, Maria, Løberg, Else-Marie

    Published in Psychiatry research (01-03-2018)
    “…The prevalence of childhood trauma (CT) in schizophrenia spectrum disorders (SSDs) and substance abuse disorders (SUDs) is high. Direct comparisons of CT in…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Compliance in schizophrenia: Psychopathology, Side effects, and patients' attitudes toward the illness and medication by RETTENBACHER, Maria A, HOFER, Alex, EDER, Ursula, HUMMER, Martina, KEMMLER, Georg, WEISS, Elisabeth M, FLEISCHHACKER, Wolfgang W

    Published in The journal of clinical psychiatry (01-09-2004)
    “…In a cross-sectional study, we investigated the influence of several factors on compliance in schizophrenia outpatients, including patients' attitudes toward…”
    Get full text
    Journal Article
  19. 19

    Prolactin Levels and Sexual Adverse Effects in Patients With Schizophrenia During Antipsychotic Treatment by RETTENBACHER, Maria A, HOFER, Alex, WOLFGANG FLEISCHHACKER, Walter, EBENBICHLER, Christoph, BAUMGARTNER, Susanne, EDLINGER, Monika, ENGL, Julia, KASER, Susanne, KEMMLER, Georg, MALIK, Peter, TSCHONER, Alexander

    Published in Journal of clinical psychopharmacology (01-12-2010)
    “…Patients with schizophrenia often experience sexual dysfunction (SD), to which disorder-related factors like negative symptoms and nondisorder-related factors…”
    Get full text
    Journal Article
  20. 20

    Osteoporosis in Patients With Schizophrenia by Hummer, Martina, Malik, Peter, Gasser, Rudolf W., Hofer, Alex, Kemmler, Georg, Moncayo Naveda, Roy Cesar, Rettenbacher, Maria A., Fleischhacker, W. Wolfgang

    Published in The American journal of psychiatry (01-01-2005)
    “…OBJECTIVE: Osteoporosis is regularly mentioned as a possible consequence of treatment with prolactin-increasing antipsychotic medications, but little is known…”
    Get full text
    Journal Article